共 202 条
[1]
Welte T(2012)Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax 67 71-79
[2]
Torres A(2012)Understanding the burden of pneumococcal disease in adults Clin Microbiol Infect 18 7-14
[3]
Nathwani D(2012)Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis Crit Care 16 R141-545
[4]
Blasi F(2012)Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia Thorax 67 540-427
[5]
Mantero M(2015)Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults N Engl J Med 373 415-1069
[6]
Santus P(2009)New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality Thorax 64 1062-755
[7]
Tarsia P(2011)European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe Drugs 71 745-902
[8]
Marti C(2012)Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults--Swedish Society of Infectious Diseases 2012 Scand J Infect Dis 44 885-E59
[9]
Garin N(2011)Guidelines for the management of adult lower respiratory tract infections--full version Clin Microbiol Infect 17 E1-iii55
[10]
Grosgurin O(2009)BTS guidelines for the management of community acquired pneumonia in adults: update 2009 Thorax Suppl 3 iii1-339